BSEAGM/EGM4d ago · 1 Sept 2026, 06:11 pm
Gist of the Proceeding of the 23rd Annual General Meeting (''AGM'') of the Company held on Tuesday, September 01, 2026.
Chandra Bhagat Pharma Ltd · 542934
✦ AI Summary
The 23rd Annual General Meeting (AGM) of Chandra Bhagat Pharma Ltd was held on September 1, 2026, where the company's financial statements for the year ended March 31, 2026, were adopted, and the reappointment of a director and the issuance of convertible warrants were approved.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Chandra Bhagat Pharma Ltd - 542934 - Shareholder Meeting / Postal Ballot-Outcome of AGM
Attachments (1)
📄pdf
Download →
354b2411-21a7-4f03-96ce-ee1a23d59aec.pdf
View document text
Date: September 01, 2026
The Manager,
BSE SME Platform
Phiroze Jeejeebhoy Towers,
Dalal St, Kala Ghoda, Fort,
Mumbai, Maharashtra 400001
BSE Scrip Code: 542934
Sub: Gist of the Proceeding of the 23rd Annual General Meeting (“AGM”) of Chandra Bhagat
Pharma Limited held on Tuesday, September 01, 2026.
Ref: Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015.
Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015 to the captioned subject, we would like
to inform you that the 23ed Annual General Meeting was held on Tuesday, September 01, 2026 at 04:00
P.M. at 323-F, Bhagat Bhuvan, Dr. Ambedkar Road, Matunga (East), Mumbai-400019, Maharashtra,
India.
A copy of the proceedings of the 23rd Annual General Meeting as required under Regulation 30 of SEBI
(Listing Obligation and Disclosure Requirements) Regulation 2015 is enclosed.
Kindly take the above information in your record.
Yours faithfully,
FOR CHANDRA BHAGAT PHARMA LIMITED
HEMANT C BHAGAT
MANAGING DIRECTOR
DIN: 00233530
PROCEEDING OF 23RD ANNUAL GENERAL MEETING OF THE MEMBERS OF CHANDRA
BHAGAT PHARMA LIMITED HELD ON TUESDAY, SEPTEMBER 01, 2026 AT 323-F,
BHAGAT BHUVAN, DR. AMBEDKAR ROAD, MATUNGA (EAST), MUMBAI-400019,
MAHARASHTRA, INDIA AT 04:00 P.M.
In accordance with provisions of Companies Act, 2013 and Articles of Association, Mr. Hemant
Chandravadan Bhagat Chairman of the meeting has welcomes to the present directors and shareholders
of Company in this 23rd Annual General Meeting of the Company.
He has introduced the present directors, Key Managerial Personnel of Company in the meeting.
The Chairman of Audit Committee was available to give the answer of Shareholders queries.
Further, Mr. Hemant Chandravadan Bhagat, being of member of Stakeholder Relationship Committee
(SRC) has also been authorised to represent the Chairman and give the answer of Shareholders queries.
The Chairman has confirmed the requisite quorum of the meeting and called the same in order.
He informed to the present shareholders of Company that Notice of the Annual General Meeting and
the Explanatory Statement along with the copies of Audited Financial Statements for the year ended
31st March, 2026, together with the Directors’ and Auditors’ Reports were already sent to the Members,
Statutory Auditors and all the Directors of the Company through email.
Further the Audited financial Statements are also available for inspection for any member at the meeting
place of the Company.
Further Members may please note that the Statutory Auditors have not made any qualifications,
observations, or comments in their Audit Report for year ended 31st March, 2026.
Thereafter the Chairman has delivered his speech, which include overview of Company’s performance
& new developments in last financial year 2025-26, growth and Company's prospect.
Also, the Chairman informed to the members that since the Company is listed on SME platform of BSE,
has been exempted from complying with e-voting requirements vide MCA Notification dated 19th
March, 2015 by amendment in Rule 20 of the Companies (Management and Administration) Rules,
2014. Hence pursuant to the notification, the e- voting facility has not been provided.
Further the Company has provided facility for voting by way of polling papers/ballot papers at the AGM
for the Members attending the meeting.
Accordingly, members whose names are recorded in the Register of Members or in the Register of
Beneficial Owners maintained by the Depositories as on the cut-off date being 25th August 2026, only
entitled to voting at the AGM.
Thereafter the chairman placed agenda items as set out in the Notice convening the AGM, to members
for their consideration and approval of:
ORDINARY BUSINESS:
1. ADOPTION OF ANNUAL ACCOUNTS;
2. RE-APPOINTMENT OF MR. PRANAV HEMANT BHAGAT (DIN: 00156362), LIABLE
TO RETIRE BY ROTATION, WHO HAS OFFERED HIMSELF FOR
RE-APPOINTMENT;
SPECIAL BUSINESS:
3. TO INCREASE IN THE AUTHORIZED SHARE CAPITAL OF THE COMPANY;
4. TO CONSIDER AND APPROVE ISSUANCE OF UPTO 66,00,000 CONVERTIBLE
WARRANTS ON A PREFERENTIAL BASIS TO PROMOTERS AND NON-
PROMOTERS FOR CONSIDERATION IN CASH.
Also, the Chairman informed the members that the results of voting during the meeting shall be
announced within two working days after receipt of Scrutinizer Report from Scrutinizer and will
intimate to the Stock Exchange and also will place on the website of the Company.
At last, the Chairman thanked the shareholders for their continued support and declared the meeting as
Concluded and proposed a vote of thanks.
The meeting concluded at 04:30 P.M.
Kindly take the above information on your records.
Yours faithfully,
FOR CHANDRA BHAGAT PHARMA LIMITED
HEMANT C BHAGAT
MANAGING DIRECTOR
DIN: 00233530